Share-based Payment Arrangement, Expense in USD of BioCardia, Inc. from 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
BioCardia, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2015 to Q3 2025.
  • BioCardia, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $77K, a 56.5% decline year-over-year.
  • BioCardia, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $521K, a 30.4% decline year-over-year.
  • BioCardia, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $741K, a 28.1% decline from 2023.
  • BioCardia, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.03M, a 12.9% decline from 2022.
  • BioCardia, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.18M, a 28.8% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

BioCardia, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $521K $77K -$100K -56.5% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $621K $98K -$86K -46.7% 01 Apr 2025 30 Jun 2025 10-Q/A 29 Oct 2025
Q1 2025 $707K $170K -$34K -16.7% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $741K $176K -$8K -4.35% 01 Oct 2024 31 Dec 2024 10-K 26 Mar 2025
Q3 2024 $749K $177K -$74K -29.5% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025
Q2 2024 $823K $184K -$133K -42% 01 Apr 2024 30 Jun 2024 10-Q/A 29 Oct 2025
Q1 2024 $956K $204K -$74K -26.6% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 $1.03M $184K -$96K -34.3% 01 Oct 2023 31 Dec 2023 10-K 26 Mar 2025
Q3 2023 $1.13M $251K -$29K -10.4% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024
Q2 2023 $1.16M $317K +$13K +4.28% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 $1.14M $278K -$41K -12.9% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q4 2022 $1.18M $280K -$144K -34% 01 Oct 2022 31 Dec 2022 10-K 27 Mar 2024
Q3 2022 $1.33M $280K -$157K -35.9% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023
Q2 2022 $1.48M $304K -$80K -20.8% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 $1.56M $319K -$97K -23.3% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023
Q4 2021 $1.66M $424K -$195K -31.5% 01 Oct 2021 31 Dec 2021 10-K 29 Mar 2023
Q3 2021 $1.86M $437K -$300K -40.7% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 $2.16M $384K -$271K -41.4% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022
Q1 2021 $2.43M $416K -$525K -55.8% 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022
Q4 2020 $2.95M $619K +$207K +50.2% 01 Oct 2020 31 Dec 2020 10-K 29 Mar 2022
Q3 2020 $2.75M $737K -$19K -2.51% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 $2.76M $655K -$41K -5.89% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 $2.81M $941K +$251K +36.4% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 $412K -$279K -40.4% 29 Jan 2020 10-K 29 Mar 2022
Q3 2019 $2.83M $756K +$26K +3.56% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020
Q2 2019 $2.81M $696K -$42K -5.69% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020
Q1 2019 $2.85M $690K +$75K +12.2% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020
Q4 2018 $2.77M $691K -$17K -2.4% 01 Oct 2018 31 Dec 2018 10-K 09 Apr 2020
Q3 2018 $2.79M $730K +$29K +4.14% 01 Jul 2018 30 Sep 2018 10-Q 19 Nov 2019
Q2 2018 $2.76M $738K +$62K +9.17% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q1 2018 $2.7M $615K -$7K -1.13% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q4 2017 $2.71M $708K -$89K -11.2% 01 Oct 2017 31 Dec 2017 10-K 09 Apr 2020
Q3 2017 $2.8M $701K +$614K +706% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018
Q2 2017 $2.18M $676K +$648K +2314% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018
Q1 2017 $1.53M $622K +$592K +1973% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018
Q4 2016 $942K $797K 01 Oct 2016 31 Dec 2016 10-K 02 Apr 2019
Q3 2016 $87K 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017
Q2 2016 $28K 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017
Q1 2016 $30K 01 Jan 2016 31 Mar 2016 10-Q 11 May 2017

BioCardia, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $741K -$289K -28.1% 01 Jan 2024 31 Dec 2024 10-K 26 Mar 2025
2023 $1.03M -$153K -12.9% 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2025
2022 $1.18M -$478K -28.8% 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2024
2021 $1.66M -$1.29M -43.7% 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023
2020 $2.95M +$230K +8.45% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022
2019 $2.72M -$52K -1.88% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021
2018 $2.77M +$67K +2.48% 01 Jan 2018 31 Dec 2018 10-K 09 Apr 2020
2017 $2.71M +$1.77M +187% 01 Jan 2017 31 Dec 2017 10-K 09 Apr 2020
2016 $942K +$659K +233% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2019
2015 $283K 01 Jan 2015 31 Dec 2015 10-K 16 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.